Literature DB >> 11888526

Polymorphism of HL +1075C, but not -480T, is associated with plasma high density lipoprotein cholesterol and apolipoprotein AI in men of a Chinese population.

Ding Z Fang1, Bing W Liu.   

Abstract

Eight hundred and twenty-three Chinese Han adults aged over 40, including 466 men and 357 women were enrolled in the study to examine the association of +1075C and -480T polymorphisms in hepatic lipase gene with plasma lipoprotein and apolipoprotein levels. In this population the allele frequencies for HL +1075C and minus -480T were 0.053 and 0.362, respectively and the prevalence of HL +1075C/C and -480T/T were 0.006 and 0.132, respectively. Overall, the normal HDL-C (> or = 35 mg/dl) subjects had a higher carrier frequency of HL +1075C than the low HDL-C (<35 mg/dl) subjects (0.108 vs 0.029, P=0.039). However, when tested separately, the carrier frequency of HL +1075C was not significantly different between normal and low HDL-C females (0.101 vs 0.083, P=0.843). In males, the normal HDL-C subjects had a higher carrier frequency of HL +1075C than the low HDL-C subjects (0.113 vs 0.018, P=0.026). No significant difference of frequencies of HL -480T genotypes -480T/T,-480C/T and -480C/C was found between normal and low HDL-C subjects. Among plasma TG, TC, HDL-C, apo AI, apo AII, apo B100, apo CII, Apo CIII and apoE, only HDL-C and apo AI were significantly different among the three genotypes +1075A/A,+1075A/C and +1075C/C in men (P=0.029 and 0.032). No association was found in women. Male subjects with CC had a higher HDL-C than those with AC (P=0.020) and AA (P=0.013), AC higher than AA (P=0.017). Male subjects with CC had a higher apo AI than AC (P=0.013) and AA (P=0.019), AC higher than AA (P=0.021). Although not so significant (P=0.053) as HDL-C and apo AI, male subjects with CC had a higher apo AII than those with AC and AA. No significant difference of lipoprotein and apolipoprotein traits was found among the three -480T genotypes -480C/C,-480C/T and -480T/T, in the sample overall and in men and women separately. These results indicate that HL +1075C, not -480T polymorphism is associated with plasma high density lipoprotein cholesterol and apolipoprotein AI in men in this Chinese population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888526     DOI: 10.1016/s0021-9150(01)00652-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia.

Authors:  Simon-Pierre Guay; Diane Brisson; Benoit Lamarche; Daniel Gaudet; Luigi Bouchard
Journal:  Epigenetics       Date:  2014-02-06       Impact factor: 4.528

2.  Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: a cross sectional study.

Authors:  Mohammad Ali Kashani Farid; Fereidoun Azizi; Mehdi Hedayati; Maryam S Daneshpour; Ahmad Reza Shamshiri; Fereydoun Siassi
Journal:  Lipids Health Dis       Date:  2010-09-07       Impact factor: 3.876

Review 3.  Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

Authors:  Eva Boes; Stefan Coassin; Barbara Kollerits; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-11-17       Impact factor: 4.032

4.  Association of an intronic haplotype of the LIPC gene with hyperalphalipoproteinemia in two independent populations.

Authors:  Hiroshi Iijima; Mitsuru Emi; Manabu Wada; Makoto Daimon; Sayumi Toriyama; Satoru Koyano; Hidenori Sato; Paul N Hopkins; Steven C Hunt; Isao Kubota; Sumio Kawata; Takeo Kato
Journal:  J Hum Genet       Date:  2007-12-27       Impact factor: 3.172

Review 5.  Utility of genetic determinants of lipids and cardiovascular events in assessing risk.

Authors:  Michael V Holmes; Seamus Harrison; Philippa J Talmud; Aroon D Hingorani; Steve E Humphries
Journal:  Nat Rev Cardiol       Date:  2011-02-15       Impact factor: 32.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.